The invention provides novel substituted azaheterocyclic compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
A compound represented by the following formula or a salt thereof
wherein each of R₁ and R₂ represents a lower alkyl group, or R₁ and R₂, together with the nitrogen atom to which they are bonded, may form a substituted or unsubstituted, saturated or partially unsaturated 4- to 8-membered heterocyclic group which may contain a hetero atom selected from N, O and S, Y represents a group of the formula -CH₂-CH₂ or -CH=CH-, and n is 0, 1 or 2. This compound is useful as anti-peptic ulcer agent